Paul Ndaya-OlooPunnee PitisuttithumNadia G. TornieporthDaniel DesgrandchampsFlor M. MunozSonali KochharJim ButteryJorgen BauwensJan BonhoefferErasmus University Medical CenterHochschule HannoverMonash UniversityUniversity of Washington, SeattleMahidol UniversityMurdoch Children's Research InstituteUniversitäts-Kinderspital beider BaselKinderspital ZürichBaylor College of MedicineSt. Luke Medical CentreMonash Children's HospitalBrighton Collaboration FoundationGlobal Healthcare Consulting2019-08-232019-08-232018-10-01Journal of Clinical Pharmacology. Vol.58, (2018), S123-S13915524604009127002-s2.0-85053676996https://repository.li.mahidol.ac.th/handle/123456789/46310© 2018, The American College of Clinical Pharmacology Vaccines are increasingly based on new constructs, new technologies, and new compounds. Novel immunization programs are rapidly implemented globally. In this article, we highlight selected hot topics of this highly dynamic and broad field of scientific and public health development. The first section focuses on novel vaccines including malaria, dengue, serogroup B meningococcal, and respiratory syncytial virus vaccines and antibodies. The second section is addressing emerging strategies and programmatic challenges including maternal immunization, integrated mother-child safety monitoring, and finally coping strategies with vaccine shortages.Mahidol UniversityMedicinePharmacology, Toxicology and PharmaceuticsArticleSCOPUS10.1002/jcph.1140